The regulatory saga of fedratinib
J Oncol Pharm Pract
.
2021 Jul;27(5):1248-1250.
doi: 10.1177/10781552211016078.
Epub 2021 May 20.
Authors
Shannon Khal
1
,
Vinay Prasad
2
,
Alison Palumbo
3
Affiliations
1
Department of Pharmacy, Providence Centralia Hospital, Centralia, WA, USA.
2
Department of Medicine, University of California, San Francisco, CA, USA.
3
Department of Pharmacy, Oregon Health and Science University, Portland, OR, USA.
PMID:
34013823
DOI:
10.1177/10781552211016078
No abstract available
Keywords:
Drug regulation; drug approval; fedratinib; myelofibrosis.
MeSH terms
Humans
Pyrrolidines*
Sulfonamides*
Substances
Pyrrolidines
Sulfonamides
fedratinib